RT Journal Article
SR Electronic
T1 Sociodemographic inequity in COVID-19 vaccine uptake among youth in Zimbabwe
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.03.10.23287107
DO 10.1101/2023.03.10.23287107
A1 Larsson, Leyla
A1 Dziva Chikwari, Chido
A1 Simms, Victoria
A1 Tembo, Mandikudza
A1 Mahomva, Agnes
A1 Mugurungi, Owen
A1 Hayes, Richard
A1 Mackworth-Young, Constance
A1 Bernays, Sarah
A1 Mavodza, Constancia
A1 Taruvinga, Tinotenda
A1 Bandason, Tsitsi
A1 Dauya, Ethel
A1 Ferrand, Rashida A
A1 Kranzer, Katharina
YR 2023
UL http://medrxiv.org/content/early/2023/03/12/2023.03.10.23287107.abstract
AB Introduction COVID-19 vaccine acceptance research has mostly originated from high-income countries and reasons why youth may not get vaccinated may differ in low-income settings. Understanding vaccination coverage across different population groups and the sociocultural influences in healthcare delivery is important to inform targeted vaccination campaigns.Methods A population-based survey was conducted in 24 communities across three provinces (Harare, Bulawayo and Mashonaland East) in Zimbabwe between October 2021 and June 2022. Youth aged 18 - 24 years were recruited using random sampling. Data on sociodemographic information and COVID-19 vaccination uptake and reasons for non-uptake were collected.Results A total of 17,682 youth were recruited (n=10,743, 60.8% female). The median age of survey participants was 20 (IQR: 19 – 22) years. Almost two thirds (n=10,651, 60.2%) of participants reported receiving at least one dose of COVID-19 vaccine. A higher proportion of men than women had been vaccinated (68.9% vs 54.7%), and vaccination prevalence increased with age (<19 years: 57.5%, 20-22: 61.5%, >23: 62.2%). Lack of time to get vaccinated, belief that the vaccine was unsafe and anxiety about side effects (particularly infertility) were the main reasons for not getting vaccinated. Factors associated with vaccination were male sex (OR=1.69, 95%CI:1.58-1.80), increasing age (>22 years: OR=1.12, 95%CI:1.04-1.21), education level (post-secondary: OR=4.34, 95%CI:3.27-5.76), and socioeconomic status (least poor: OR=1.32, 95%CI:1.20-1.47).Conclusion This study found vaccine inequity across age, sex, educational attainment and socioeconomic status among youth. Strategies should address these inequities by understanding concerns and tailoring vaccine campaigns to specific groups.What is already known on this topic Many countries have faced challenges when rolling out COVID-19 vaccines. Infrastructure, logistics, misinformation and vaccine hesitancy have been barriers to vaccine access and uptake globally. Vaccine nationalism by high-income countries has particularly affected countries in Africa and Asia, resulting in inequity between countries and regions.What this study adds Vaccine uptake among youth in Zimbabwe was more than 50% across all age-groups. Men, those with more education and those living under less socially deprived socioeconomic conditions were more like to be vaccinated. Fear of side effects and myths circulating on social media were barriers. Religion was less of a barrier than other studies reported, likely due to religious institutions’ collaborations in COVID-19 vaccination efforts.How this study might affect research, practice or policy Vaccination campaigns should actively address specific concerns of communities, especially concerns around fertility and early death, and provide vaccines in easy-access and convenient locations. Involving community leaders in both education and vaccination efforts is pivotal given the trust and influence they have.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://wellcomeopenresearch.org/articles/7-54 Funding StatementThe CHIEDZA study is funded by the Wellcome Trust (Senior Fellowship to RAF: 206316/Z/17/Z)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study received ethical approval from the Medical Research Council of Zimbabwe (MRCZ) (MRCZ/A/2387), the BRTI Institutional Review Board (IRB) (AP149/2018) and the London School of Hygiene and Tropical Medicine (LSHTM) ethics committee (16124).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors